Finding its ‘niche’: start-up Scholar Rock targeting growth factors

By Jennifer BoggsManaging Editor

Thursday, February 27, 2014

Scholar Rock Inc. CEO Nagesh Mahanthappa’s previous biopharma experiences include stints at RNAi powerhouse Alnylam Pharmaceuticals Inc. and privately held Avila Therapeutics Inc., and he is the first to admit that “those are high standards.”